Early MS drug safety study halted after just 4 volunteers
Symptom relief
Terminated
This early-phase study aimed to check if a single dose of bryostatin is safe for people with multiple sclerosis who are already on standard treatments. Only 4 participants were enrolled before the study was stopped. Researchers tracked side effects and brain inflammation using MR…
Phase: PHASE1 • Sponsor: Robert Fox • Aim: Symptom relief
Last updated May 26, 2026 05:50 UTC